A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
With a estimate 5 year intrinsic value of over $100+ this stock is currently selling at a discount. I like this stock for the long haul as it's been a very predictable stock the past 10 years so I am comfortable assuming it can/will reach $90 in that time period.
You do realize that at $90-100 the P/E ratio will be around 30, right? Or are you saying their earnings are going to grow 50% over the next five years?
Earnings aren't the only thing a company represents. Look at how BV has grown over the past 8 or so years and you can see how the value of the company is greater than just the P/E ratio. My valuation is only about $77 per stock of value but people use different numbers to estimate things so I'm sure a valuation in the $90 range is possible, especially since the company directly returns so much of its cash to investors directly through its dividends.